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Antimicrobial peptides (AMPs) are important effector molecules of the innate immune 
system. They are mostly cationic in nature and kill bacteria mainly by direct disruption of 
microbial cell membranes. In addition to antimicrobial properties, many AMPs stimulate 
the production of cytokines and chemokines. Cathelicidins constitute a major family of 
AMPs sharing a highly conserved precursor sequence at the amino-terminal region. 
Cathelicidins are generally synthesized from granules of leukocytes and macrophages as 
well as mucosal epithelial cells and skin keratinocytes. We have provided an extensive 
review of the literature on AMPs in Chapter 1. In chickens, four cathelicidins have been 
identified, known as fowlicidins 1-3 and cathelicidin B1. However, little is known about 
their tissue and developmental expression patterns. In Chapter 2, we quantitated the 
expression of four chicken cathelicidins in a large panel of tissues by real-time PCR. We 
also studied how the expressions of these four cathelicidins differ during the development 
of chickens from 2- to 28-days of age. We concluded that cathelicidins may function to 
protect chickens from infectious agents and environmental stress upon hatching until the 
immune system is fully established. Earlier work in this lab has revealed
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that synthetic fowlicidins 1-3 possess potent antibacterial activities against a broad 
spectrum of microorganisms. Among all fowlicidin 9 analogs, carboxyl-terminal 
amidated fowl-1(6-26)-NH2, capable of killing antimicrobial resistant bacteria, such as 
methicillin-resistant Staphylococcus aureus, both in vitro and in vivo, remains active at 
physiological salt concentrations and in the presence of serum. 
Therefore, fow-1(6-26)-NH2 has potential for further development as a novel 
antibacterial drug. However, the disposition of fow-1(6-26)-NH2 with regard to its 
absorption, distribution, metabolism, and excretion following in vivo administration is 
presently unknown. As a first step to estimate its disposition, we have sought to develop 
and validate a liquid chromatography and tandem mass spectrometry (LS-MS/MS) 









The discovery of penicillin as an antibiotic by Alexander Fleming was considered a great 
advancement in science (1). Since then, hundreds of antimicrobial drugs have become 
commercially available and impact enormously on the public health. Mechanisms of 
action of antibiotics mainly include interference with the synthesis of bacterial cell walls, 
proteins and nucleic acids, inhibition of metabolic pathways, and disruption of bacterial 
membrane structure (2). However, the extensive use of antibiotics has also led to the 
rapid emergence of microorganisms that are resistant to antimicrobial agents (3). This 
resistance is primarily achieved through the acquisition of resistance genes from other 
microorganisms as in the case of Staphylococcus aureus (2). The resistance genes enable 
bacteria to produce antibiotic-inactivating enzymes, express drug-efflux systems, modify 
the drug target sites, or acquire new metabolic pathways that bypass the action of the 
drug (2). 
Hence, the development of novel antibiotics with less likelihood of provoking bacterial 
resistance is critically important in ensuring public health. Antimicrobial peptides, a large 
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group of natural antibiotics produced by virtually all species of life, are being actively 
explored as a new generation of antibacterial drugs. 
DISCOVERY OF ANTIMICROBIAL PEPTIDES 
 Antimicrobial peptides (AMPs) are endogenous peptides of less than 100 amino acids 
that constitute an important component of the innate immune system. They are found in 
almost all species of life ranging from bacteria to yeasts and from plants to invertebrate 
and vertebrate animals (4). AMPs of animal origin are primarily produced from 
phagocytes as well as epithelial cells of the skin and gastrointestinal, respiratory, and uro-
genital tracts (5). In general, AMPs are synthesized as precursor molecules, which have a 
signal and propeptide sequence. They are cleaved to form mature peptides (6). They have 
a broad spectrum of antimicrobial activity against bacteria, parasites, viruses, and fungi. 
Besides antimicrobial properties, they play an important immunomodulatory role in 
chemotaxis of immune cells, modulation of cell surface receptors and alteration in gene 
expression (4). AMPs also bridge the innate and adaptive immune systems. AMPs 
interact with dendritic cells, T cells and B cells to indirectly eradicate pathogens by either 
activating or inhibiting the production of chemokines and cytokines (7). 
MECHANISM OF ACTION  
Most AMPs kill microbes by disrupting cell membranes of microorganisms, similar to 
other innate immune components such as complement proteins, where killing occurs by 
membrane attack complex formation. Cationic AMPs interact with anionic cell 
membranes of bacteria, fungi, parasites and enveloped viruses (8). They penetrate into 
the cells and disrupt the microbial cell membranes either by pore formation or by 
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detergent-like solubilization (9). Three models have been proposed to explain membrane 
permeabilization: i. In the barrel stave model, peptide helices form pores into the bilayer, 
where the hydrophobic region of peptides align with lipid core of the bilayer and the 
hydrophilic region forms central region of the pore, ii. In the carpet model, peptides 
electrostatically bind to the membrane and spread over the bilayered membrane in a 
carpet like manner that eventually led to the formation of micelles and, iii. In toroidal 
pore model, the pore formation is similar to barrel stave model, but the antimicrobial 
peptide helices insert into the membrane in such a way that it induces the lipid bilayer to 
bend continuously through the pore so that the peptides are always associated with lipid 
head groups (10). In all these models, changes in membrane permeability lead to death of 
the microorganisms. However, non-membrane lytic mechanisms also exist for a few 
AMPs (11, 12). For example, PR-39 causes cell death by inhibiting bacterial protein 
synthesis (9), whereas human neutrophil defensins have been demonstrated to suppress 
DNA and protein synthesis (13) and mersacidin inhibits cell wall synthesis (14). Because 
of a difference in the membrane net charge, lipid composition, and transmembrane 
potential between bacterial and mammalian cell membranes, AMPs shows weak or no 
lytic activity toward mammalian cells (8). 
CLASSIFICATION OF ANTIMICROBIAL PEPTIDES  
AMPs are classified into four classes based on their charge, structure, sequence 
homology, and functional properties (7). They include: 1) linear cationic α-helical 
peptides, e.g., cercopins, chicken cathelcidins, LL-37, and SMAP-29; 2) peptides rich in 
certain amino acids, e.g., PR-39 rich in arginine and proline and indolicidin rich in 
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tryptophan; 3) β-sheet peptides consisting of one or multiple disulfide bonds, e.g., 
protegrins, human α- and β-defensins; and 4) anionic peptides, e.g., dermicidins (15). 
In vertebrates, defensins and cathelicidins represent two major families of AMPs. 
Defensins are cationic peptides that contain 6-8 cysteine residues. Disulfide bridge 
formation is the characteristic feature of defensins, which are further grouped into three 
subfamilies, namely α-, β-, and θ-defensins, based on the cysteine spacing pattern and 
disulfide bond linkage (9). In humans, the α-defensins such as human neutrophil 
defensins (HNPs) 1-4 and human alpha defensin (HD) 5-6 are abundantly expressed in 
the granules of neutrophils and intestinal paneth cells respectively(16, 17). In addition to 
the antibacterial activity, α -defensins show an increased expression of TNF-α and IL-1 in 
activated macrophages (9) and also exhibit potent antiviral activity mainly against 
adenoviruses (18). There are over 35 distinct β-defensins reported in humans (9), whereas 
a total of 14 β-defensins exist in chickens (19, 20). Besides antibacterial activities, other 
immune related functions of β-defensins include promotion of histamine release and 
prostaglandin D2 production in mast cells (21).  
Cathelicidins consist of a highly conserved prepropeptide sequence (cathelin) and an 
extremely variable carboxyl-terminal cationic, biologically active peptide. Cathelicidins 
are synthesized in bone marrow myeloid cells as prepropeptides. They are converted to 
proform by the removal of signal peptide, and then stored in the large granules of 
neutrophils (22). The conserved prosequence plays a role in targeting the antimicrobial 
peptides to the granules and also assists in correct proteolytic maturation. The 
prosequence is highly identical to the sequence of a protein called cathelin. Hence, the 
term cathelicidin is used, to indicate that this group contains cathelin-like proregion and a 
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C-terminal antimicrobial domain (23).The enzyme elastase cleaves off the N-terminal 
conserved region to produce matured antimicrobial peptide (24). LL-37 is the only 
cathelicidin found in humans (25), whereas four cathelicidins have been identified in 
chickens (26, 27). Chicken cathelicidins are termed as fowlicidins 1-3 and cathelicidin 
B1. Cathelicidin B1 is so called because of its selective expression in the bursa of 
fabricius (26). 
THERAPEUTIC EFFECTS OF ANTIMICROBIAL PEPTIDES  
AMPs have been shown to be effective in killing of various infectious agents like 
bacteria, virus, fungi and parasites. Production of endogenous AMPs is often positively 
correlated with infectious disease resistance. For example, a decrease in the expression of 
LL-37 and HBD-2 in human patients with atopic dermatitis has been linked to increased 
susceptibility to skin infections (28). A lack of cathelicidin expression in humans is 
considered to be a major cause in Kostamann’s syndrome (9). Similarly, inhibition of 
cathelicidins in pigs enhanced bacterial colonization before the innate immune cells are 
activated (29). Similarly, Howell and their colleagues showed that an increased 
expression of AMPs in keratinocytes during inflammation resulted in an enhanced 
activity against Staphylococcus aureus, Herpes Simplex Virus, and Vaccinia Virus (30).  
In addition to antimicrobial activity, AMPs play an important role in wound repair, 
angiogenesis, and immunomodulation. Inhibition of LL-37 by anti-LL-37 antibodies 
reduced wound healing (31) via suppression of the proliferation of keratinocytes (31, 32). 
Development of blood vessels was also noted in tissue cultures as well as in rabbit 
models by following addition of LL-37 (32). Because of pleiotropic effects beyond direct 
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antimicrobial actions, AMPs are being actively explored as a new class of antibiotics. 
Pharmacokinetic studies of several AMPs are currently being pursued (45, 46). 
LIQUID CHROMATOGRAPHY AND TANDEM MASS SPECTROMETRY   
(LC-MS/MS)  
Pharmacokinetics of drugs is traditionally studied using enzyme linked Immunosorbent 
assay (ELISA), radio immunoassay, high performance liquid chromatography (HPLC), 
etc. However, immunoassay methods have certain limitations, such as time consuming 
steps in production of polyclonal or monoclonal antibodies against protein, cross 
reactions with precursors of target protein, and inability to identify the metabolized 
products of the protein (33). With the advent of new technologies, liquid chromatography 
and tandem mass spectrometry (LC-MS/MS) has gained much attention because of its 
sensitivity and specificity in detecting proteins/peptides as well as metabolic products. 
LC-MS/MS is a combination of high performance liquid chromatography and tandem 
mass spectrometry. Substances of interest are separated on a high performance liquid 
chromatography (HPLC) and then analyzed through a mass spectrometer. Acquisition of 
data involving scans of ion selection and its fragments is known as tandem mass 
spectrometry (MS/MS) (34). MS/MS increases the selectivity and specificity in the 
identification of drugs and also assists in analyzing the structural modifications that occur 
during metabolism of the drugs. 
The principle of mass spectrometry is to generate ions from compounds and separate 
these ions based on their mass over charge ratios (m/z). These compounds are detected 
qualitatively and quantitatively based on their ions and abundance (48). The mass 
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spectrometer is comprised of an ion source, mass analyzer, and ion detector. Electrospray 
ionizes the sample at atmospheric pressure and then transfers it in to a mass spectrometer. 
A strong electric field is applied to a liquid, which assigns charge to these liquid droplets. 
The charged droplets are then heated up with inert gas like nitrogen to evaporate the 
solvent. The drop elongates under pressure and then attains taylor cone (48). There are 
many types of mass analyzers which include time-of-flight, quadrupole, ion trap, 
orbitrap, and fourier transform ion cyclotron resonance analyzer. Ions from mass 
analyzers are detected either by electron multipliers or Fourier transformation detectors. 
Recent advances in LC-MS/MS have allowed ionization on a nano scale. Nano-spray 
ionization (NSI) favors injection of a low volume of analytes, thereby reducing sample 
loss and system failure (35) with higher sensitivity and better signal to noise ratio (36). 
NSI is been applied to detect various pharmaceutical compounds, including proteins (37-
39). 
APPLICATIONS OF LC-MS/MS IN PHARMACOKINETIC STUDIES OF 
ANTIMICROBIAL PEPTIDES  
LC-MS/MS has become perhaps the most widely applied technique in pharmacokinetic 
studies of drugs. A validated method should define specificity, recovery, lower limit of 
quantitation, accuracy, and precision of measurements (40). Sample pretreatment has 
become a crucial step for maximum recovery of the drug from biological matrices. Direct 
injection of plasma samples into LC-MS/MS interferes with ionization and also poses the 
danger of clogging the LC column. Plasma protein precipitation, solid-phase extraction, 
and liquid-liquid extraction are among commonly used techniques for sample 
pretreatment. Solvents used in protein precipitation often include ammonium sulfate, 
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aluminum chloride (5%, w/v), n-phosphoric acid (5%,w/v), trichloroacetic acid (TCA) 
(10%, w/v), zinc sulfate (10%, w/v), 0.5 N sodium hydroxide, ammonium acetate, 
acetonitrile, ethanol, or methanol (41). 
All precipitants except ammonium sulfate and aluminum chloride were shown to be 
approximately 90% effective in precipitation of proteins at a volume ratio of 2:1 
(precipitants: plasma). Although all precipitants proved to be effective, organic solvents 
are widely utilized for protein precipitation in drug analysis (41). Among ethanol, 
methanol, and acetonitrile, acetonitrile is considered a superior organic solvent when 
used at a ratio of <2:1 (precipitant: plasma). However, there are reports of direct injection 
of plasma samples without prior treatment. For example, plasma samples spiked with a 
peptide, AM336, were directly injected into a single polymer-coated mixed function 
(PCMF) column (42). Results are presented in single ion reaction monitoring, where a 
specific ion of interest is scanned.  
Application of the OrbitrapTM (Thermo Fischer Scientific, MA, USA) mass 
spectrometer was reported for identifying the isotopic distributions of the parent ion and 
protonated fragment ions of vancomycin, a cyclic glycopeptide antibiotic (43). Multiple 
reaction monitoring (MRM) scan mode was applied in the analysis of protein 
phosphorylation sites on novel proteins within a signal network (44). Increased selectivity 
is obtained through SRM scan when compared to full and SIM scan (44). However, there 
are reports that MRM cannot be employed in quantifying the fragment ions of glucagon 
(45), due to the formation of many product ions with low intensities. Glucagon was found 
to ionize to form multiple charged states and shown that an alteration in capillary voltage 
led to the appearance of its most intense signal peak with +4 charged state (45), which 
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shows the importance of tuning of mass spectrometer settings for detection of the most 
intense peak from a multiply charged compounds. LC-MS/MS was applied to measure 
pharmacokinetic parameters of two cationic antimicrobial polymixin peptide analogs, 
NAB 7061 and NAB 739, following parenteral injection into rats (46). The limit of 
quantification (LOQ) for NAB 7061 was 0.125mg/L, while the LOQ of NAB 639 was 
0.010mg/L and 0.050mg/L in acetonitrile-treated plasma and urine, respectively. A 
similar study was performed by using liquid chromatography – electrospray ionization- 
quadrupole time of flight (LC-ESI-QTOF) for plectasin, a peptide antibiotic obtained 
from saprophytic fungi (47). 
CONCLUDING REMARKS  
AMPs are being actively explored for their potential as novel antibiotics. The 
pharmacokinetic properties of these peptides need to be determined before large-scale 
clinical trials can occur. Therefore, it is essential to develop a reliable analytical approach 
to quantification of AMPs in biological samples and LC-MS/MS appears to be the 
method of choice. 
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TISSUE EXPRESSION AND DEVELOPMENTAL REGULATION OF CHICKEN 
CATHELCIDINS 
ABSTRACT  
Cathelicidins represent a major family of vertebrate antimicrobial peptides that are an 
important component of innate immunity. Four cathelicidins, namely fowlicidins 1-3 and 
cathelicidin B1, have been found in chickens. However, little is known about their tissue 
and developmental expression patterns. In this study, we examined the expression of four 
cathelicidins in a large panel of tissues in 28-day-old chickens by real-time PCR. We also 
investigated the expression patterns of these four cathelicidins in chickens of different 
ages in order to understand the significance of cathelicidins during early development. 
We showed that all four cathelicidins were widely expressed in a variety of tissue types, 
with fowlicidins 1-3 showing a more similar pattern in four genes expression than 
cathelicidin B1. Fowlicidins 1-3 has the highest expression level in the lung, whereas 
cathelicidin B1 is expressed most abundantly in the bursa. We further revealed that four 
cathelicidins are differentially expressed during the early stage of development, largely 




Collectively, our results suggested that chicken cathelicidins may play an important role 
in the protection of chicks from harmful agents during early development and before the 
immune system fully matures. 
INTRODUCTION 
 Antimicrobial peptides (AMPs) are important effector molecules of the innate immune 
system with both bacterial killing and immunomodulatory activities (1). Cathelicidins, 
consisting of a highly conserved N-terminal pre-pro-sequence and a variable C-terminal 
mature sequence, are a major family of AMPs in vertebrate animals (2). In chickens, four 
cathelicidins, including fowlicidins 1-3 and cathelicidin B1 were recently identified (10, 
11). Studies with limited tissue types revealed the expression of these chicken 
cathelicidins primarily in epithelial cells of mucosal tissues (20). A recent work also 
investigated the expressions of chicken cathelicidins and many other host defense genes 
during embryonic development (3). Fowlicidins 1-3 were expressed on day 3 and 
increased up to day 6 of development. Their expression levels were reduced on day 9 and 
subsequently increased in day 12 embryos. Cathelicidin B1 was not expressed until day 
9. The expression pattern of fowlicidins 1-3 shows a similar profile, suggestive of their 
close phylogenetic relationship, whereas cathelicidin B1 expression was different 
indicating its distant evolutionary relationship from fowlicidins (12). 
In this study, we investigated the tissue expression pattern of four chicken cathelicidins in 
a large panel of 23 different tissues of 28-day-old broiler chicks. Further, we examined 
the expression of four cathelicidins in bursa of Fabricius, lung, cecum, and cecal tonsils 
from 2- to 28-day-old chickens. 
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MATERIALS AND METHODS 
 Tissue collection and processing: One-day-old broiler chickens were purchased from a 
commercial hatchery and reared under standard care in the Lab Animal Resource Facility 
at Oklahoma State University. The chickens were given free access to commercial diets 
and water. A large panel of tissues was collected at various ages (day 2, 4, 7, 14 and 28), 
with 3-5 birds per age group. Cervical dislocation of chicken was performed and a total 
of 23 tissues were harvested, including crop, esophagus, proventriculus, gizzard, 
duodenum, jejunum, ileum, cecal tonsil, cecum, colon, lung, heart, trachea, liver, spleen, 
thymus, kidney, skin, breast muscle, brain, testis, ovary, and bursa of Fabricius. The 
tissue samples were snap frozen in liquid nitrogen and stored at -80oC until use.  
Isolation and quantification of total RNA: Tissues were homogenized in Tri Reagent 
(Sigma Aldrich, MO), followed by total RNA extraction according to the manufacturer’s 
instructions. Tri reagent contains guanidinium thiocyanate and phenol, which are 
involved in disruption of cells. Tri reagent maintains the integrity of RNA. The air-dried 
RNA pellet was suspended in nuclease-free water and mixed thoroughly until the pellet 
was completely dissolved in nuclease free water. RNA quantity and its purity were 
measured in duplicate using a Thermo Scientific NanoDropTM Spectrophotometer 
(NanoDrop, Wilmington, De, USA). RNA concentration of all tissues was determined at 
260nm. The purity of RNA was assessed by the ratio of absorbance at OD 260/280nm 
and OD 260/230nm. 
 Reverse transcription of total RNA: QuantiTect® Reverse Transcription Kit (Qiagen 
Inc.) was used to reverse transcribe total RNA into the first-strand cDNA following the 
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manufacturer’s recommendations. Briefly, 0.3µg of total RNA was first freed from 
genomic DNA contamination in a genomic DNA wipeout buffer for 5 min at 42oC. 
Genomic DNA wipeout buffer contains DNase enzyme, which denatures DNA. Reverse 
transcription was performed in a total volume of 4 µL using Quantiscript® reverse 
transcriptase and a mixture of random hexamers and oligo(dT) primers for 30 min at 
42oC, followed by 3 min at 95oC to inactivate the reverse transcriptase. The 1st strand 
cDNA concentration was then measured using the Thermo Scientific NanoDropTM 
Spectrophotometer (NanoDrop, Wilmington, De, USA) following 10-fold dilution in 
nuclease-free water.  
Real time PCR: QuantiTect® SYBR Green PCR Kit (Qiagen Inc.) was used for real-time 
amplification of the first-strand cDNA using MyiQ real-time PCR detection system (Bio-
Rad Inc.) as previously described (4). Briefly, each PCR reaction was set up in a 96-well 
PCR plate in a total volume of 10 µL using 0.1 µg of the first strand cDNA. A volume of 
10µL contains 9µL of SYBR green PCR master mix, sense and antisense primers (Table 
1), and 1µL of cDNA. Real time PCR was programmed as follows: initial denaturation at 
95oC for 10 min, followed by 45 cycles of denaturation at 94oC for 15s, annealing at 55oC 
for 20s, and extension and data collection at 72oC for 30s. Comparative ∆∆CT method 
was used for quantification of gene expression as mentioned by PE Applied Biosystems 
(Perkin Elmer, Forster city, CA) (5). Normalization was done by using GAPDH as the 
reference gene. Tissue with highest CT value was used as a calibrator. Delta CT value for 
all tissues were calculated by subtracting CT values of GAPDH from CT values of target 
tissues and then delta-delta CT values were calculated by subtracting the highest ∆CT 
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value obtained for one tissue. Relative fold difference was computed by using the 
formula 2-∆∆Ct (Table 2) (5, 6). 
Statistical Analysis: All data were analyzed with one-way ANOVA, followed by Tukey’s 
multiple comparison test using Graph Pad Prism 5 (Graph pad software, San Diego, 
California). The results were considered significant, if p< 0.05. 
RESULTS 
 RNA quality and statistical analysis: Our data showed that the quantity of RNA of all 
tissues obtained was more than 300ng/ml and the quality by OD260/ OD280 nm, and 
OD260/ OD230nm absorption ratios were within the range of 1.8-2.0, which indicated that 
RNA was in good quality without any contamination from aromatic amino acid, proteins, 
guanidinium thiocyanate, and phenol. The data was normally distributed, verified by 
computing the value of (mean- 0.67 standard deviation) and compared with 25 percentile 
(18). 
Tissue expression patterns of chicken cathelicidins: As shown in Fig. 1, all four 
cathelicidins were widely expressed in a variety of tissue types, with fowlicidins 1-3 
showing a distinct and similar pattern in gene expression as compared to cathelicidin B1.  
Fowlicidins 1-3 were expressed throughout the digestive and respiratory tracts, with the 
highest expression in the lung (Fig. 1), consistent with the role of AMPs in mucosal host 
defense. On the other hand, although the cathelicidin B1 gene was also expressed in the 
digestive and respiratory tracts, the bursa of Fabricius was the dominant tissue where 
cathelicidin B1 is expressed (Fig. 1), in agreement with an earlier report (7). All four 
cathelicidins were also expressed abundantly in all four primary and secondary lymphoid 
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organs examined, including thymus, spleen, cecal tonsil, and bursa of Fabricius. The only 
tissue that showed no obvious expression of all four cathelicidins is breast muscle      
(Fig. 1). 
Developmental expression of chicken cathelicidins: The variation in chicken 
cathelicidin expressions among different age groups of chickens was determined. As 
compared to that on day 2, an enhanced expression of all four cathelicidins was observed 
in the bursa of fabricius on day 4, and then the expressions were gradually decreased to 
the day 2 level on day 28 (Fig. 2). Interestingly, we observed an almost completely 
opposite trend with cecal tonsil, another immune organ unique in birds (Fig. 3).When 
compared to other tissues, cecal tonsils were only harvested from 7-, 14-, and 28-day-old 
chicks because of an inability to obtain sufficient sample mass at earlier ages. Relative to 
7-day-old chickens, 14-day-old chickens showed an increased expression of cathelicidin 
B1, followed by a reduced expression in 28-day-old chickens, whereas a gradual increase 
of fowlicidins 1-3 expression was noted (Fig. 3). 
In the cecum, the expressions of fowlicidins 1-3 remained largely unchanged during the 
first two weeks of age and then significantly increased on day 28 by as much as 25-fold 
in the case of fowlicidin-3 (Fig. 4). Cathelicidin B1 gene expression in the cecum showed 
a different pattern, with a significant decrease on day 7 as compared with day 2 or day4, 
followed by an age-dependent increase at day 28 (Fig. 4). On the other hand, there was 
no obvious difference during the first four weeks of development in the expression of 
four cathelicidin genes in the lung (Fig. 5), another mucosal tissue with the most 
abundant expression of three fowlicidins (Fig. 1). We also noted that cathelicidin B1 
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showed a relatively high, but statistically insignificant increase in the expression on day 
14, relative to other age groups. 
DISCUSSION 
We determined both tissue and developmental expression patterns of four chicken 
cathelicidins in this study through RNA isolation, cDNA preparation, and quantifying 
fold difference in the gene expression. Comparative CT method is the most widely used 
method for relative quantification in real-time RT PCR where inclusion of control levels 
standardize each reaction run with respect to RNA integrity, sample loading, and inter 
PCR reactions (5). Hence, in our study, RNA integrity was not verified through gel 
electrophoresis. GAPDH is used as housekeeping or reference gene for normalization, 
considering its mRNA synthesis to be constant in various tissues under experimental 
conditions (8). GAPDH normalizes the samples for differences in the amount of total 
RNA added to cDNA preparation and also normalizes the variations in reverse 
transcription efficiency among different cDNA reactions. Reports have demonstrated that 
the reference genes are regulated and vary under experimental conditions (9). But, in our 
study, reference gene values showed little or no variation among various tissues (Table 
2). The fold difference in the expression of four cathelicidin genes revealed that they are 
expressed in a broad range of tissue types, consistent with earlier reports with limited 
tissue types (10). A comparative study of chicken genes in ileum, liver, cecal tonsil and 
spleen revealed that the antimicrobial peptides such as defensins 1, 2, 6 and 7 were highly 
expressed in spleen when compared to other tissues (11). Meade et al., studied the 
developmental expression pattern of all chicken cathelicidins in fertilized chicken eggs, 
which inferred that four cathelicidins are phylogenetically related (3). Fowlicidins 1-3 
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were most abundantly expressed in the lung, whereas cathelicidin B1 was highest in the 
bursa of Fabricius. It’s noteworthy that bone marrow was also the place that actively 
synthesized many AMP transcripts including cathelicidins, but was not included in our 
study (7). 
Interestingly, chicken cathelicidin expression levels were minimal in the skin of chickens, 
which is in contrast with many mammalian species. This difference could be attributed to 
species variation or the evolution of skin development in different species. The scenario 
is different in the case of humans, where human epidermal cells express abundant levels 
of LL-37 (7). Human skin can act either as a route of entry or as a site for replication for 
microorganisms. In order to prevent microbial invasion and their multiplication, skin has 
to synthesize host defense factors including cathelicidins for its immediate protection. 
Majority of the infectious agents gain entry in to the body of chickens through feco-oral 
route (17). Hence, AMPs synthesis might not be required in the skin. However, a high 
level of fowlicidin-2/CMAP27 expression was reported in the uropygial (preen) gland 
tissue of chickens (12), which secretes wax and oil that spreads over plumage and 
feathers. Therefore, it seems possible that CMAP 27 provides protection against skin 
infections in chicken. 
The expression of cathelicidins in bursa was inversely related to the age of the bird. 
Expression of cathelicidin genes gradually decreased as birds matured (Fig. 2). This 
expression pattern could be correlated with the growth of the bursa, which takes place 
rapidly up to 9 weeks of age and slows thereafter (17). The mucous membrane of the 
bursa has long folds termed as plicae which resemble villous projections (13). Each plica 
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has a large number of follicles separated by connective tissue. Inactive primary lymphoid 
follicles were observed in day-old chicks while development of secondary (active) 
lymphoid follicles was noticed from 7-day-old chicks (17). Ratcliffe demonstrated that 
bacterial antigens from the gastro-intestinal tract gain access to the bursa of Fabricius and 
may involve in the activation of innate and adaptive immunity (14). It is possible that 
bursa of Fabricius might have expressed effector molecules of innate immunity like, 
cathelicidins to protect from invading microorganisms. Cathelicidin expression has been 
reduced from 7th day onwards due to development of active T and B cells.  
The results observed in cecum and cecal tonsil suggested that the expression of 
cathelicidin was enhanced during development, likely due to exposure to normal 
microflora. Shapiro et al., reported that commensal bacteria colonizes in the gastro-
intestinal tract of chicken within 24 hours of hatching (15) and the density of these 
microflora is greater in the distal region of the intestine. Evidence showed that a diverse 
group of bacteria, such as genera of Bacteriodes, Bifidobacterium, Clostridium, 
Enterococcus, Escherichia, Fusobacterium, Lactobacillus, Streptococcus, and 
Campylobacter resides in the cecum (15). The commensal microflora is beneficial in 
preventing the colonization of pathogenic microorganisms by forming biofilms on 
intestinal epithelium and blocking the pathogens from entry (16). However, excessive 
proliferation of these commensal bacteria may become pathogenic to chickens. 
Therefore, production of chicken cathelicidins is essential to maintain intestinal 
homeostasis. In addition to the gene expression of cathelicidins in healthy chickens, 




Our study of tissue and developmental expression patterns of four chicken cathelicidins 
has led to a better understanding of the chicken innate immunity as well as the 
development of the innate immune system. The results from this study suggest that the 
differential expression of cathelicidins in mucosal and immune tissues might play an 
important role in the protection of chicks from harmful agents during early development 
and before the immune system is fully functional.  
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Table 2: An example of calculation of fold change of cathelicidin B1 in bursa of 




Table 1:  Forward and reverse primers of genes used in quantitative RT-PCR. 




   GCACGCCATCACTATCTTCC 
 
   CATCCACCGTCTTCTGTGTG 
g CATH B1    CCGTGTCCATAGAGCAGCAG  AGTGCTGGTGACGTTCAGATG 
Fowlicidin-1  GCTGTGGACTCCTACAACCAAC GGAGTCCACGCAGGTGACATC 
Fowlicidin-2  CAAGGAGAATGGGGTCATCAG CGTGGCCCCATTTATTCATTCA 





Table 2:  An example of calculation of fold change of cathelicidin B1 in bursa of 






ct dct avg dct ddct 
fold 
change 
D2#1 16.11 29.75 -13.64   -0.81 1.753211 
  16.33 30.53 -14.2   -1.37 2.584706 
D2#2 15.76 29.61 -13.85   -1.02 2.027919 
  15.93 29.96 -14.03   -1.2 2.297397 
D2#3 15.98 30.08 -14.1   -1.27 2.411616 
  15.94 30.59 -14.65   -1.82 3.530812 
D4#1 15.43 30.51 -15.08   -2.25 4.756828 
  15.5 29.9 -14.4   -1.57 2.969047 
D4#2 15.83 30.09 -14.26   -1.43 2.694467 
  15.31 30.4 -15.09   -2.26 4.789915 
D4#3 15.65 29.64 -13.99   -1.16 2.234574 
  15.81 29.67 -13.86   -1.03 2.042024 
D7#1 16.92 29.91 -12.99   -0.16 1.117287 
  16.83 29.86 -13.03   -0.2 1.148698 
D7#2 16.29 29.45 -13.16   -0.33 1.257013 
  16.14 29.29 -13.15   -0.32 1.248331 
D7#3 14.76 29.24 -14.48   -1.65 3.138336 
  14.72 29.49 -14.77   -1.94 3.837056 
D14#1 16.8 29.13 -12.33   0.5 0.707107 
  16.74 29.41 -12.67   0.16 0.895025 
D14#2 15.38 28.97 -13.59   -0.76 1.693491 
  15.36 29.04 -13.68   -0.85 1.802501 
D14#3 16.98 30.05 -13.07   -0.24 1.180993 
  16.68 30.82 -14.14   -1.31 2.479415 
D28#1 17.35 30.09 -12.74 -12.83 0.09 0.939523 
  16.88 30 -13.12   -0.29 1.22264 
D28#2 17.05 29.92 -12.87   -0.04 1.028114 
  17.26 30 -12.74   0.09 0.939523 
D28#3 16.71 28.44 -11.73   1.1 0.466516 
  17.55 31.33 -13.78   -0.95 1.931873 
     Note: dct = Cath B1 CT - GAPDH CT; avg dct is average of control;  
           ddct = dct of target - avg dct of control; fold change = 2-^ddct. 
  
Table 2:  An example of calculation of fold change of cathelicidin B1 in bursa of 






Note: Chart showing amplification curves of both GAPDH (right) and Cathelicidin B1 
(left) genes in the bursa of Fabricius. 
 
FIGURE LEGENDS 
Figure 1. Tissue expression patterns of four chicken cathelicidin genes. The 
expression patterns were obtained by real-time RT-PCR of total RNA isolated from 28-


































































































































































Figure 2. Developmental expression of four chicken cathelicidins in the bursa of 
Fabricius. Bursas were harvested from chickens of 2, 4, 7, 14, and 28 days of age and 
subjected for RNA isolation and real-time PCR analysis of individual chicken 
cathelicidins. Each bar represents mean ± SEM of three chickens. Means with different 






Figure 3. Developmental expression of four chicken cathelicidins in the cecal tonsil. 
Cecal tonsils were harvested from chickens of 7, 14, and 28 days of age and subjected for 
RNA isolation and real-time PCR analysis of individual chicken cathelicidins. Each bar 
represents mean ± SEM of three chickens. Means with different letters are significantly 












































































Figure 4. Developmental expression of four chicken cathelicidins in the cecum. 
Cecum was harvested from chickens of 2, 4, 7, 14, and 28 days of age and subjected for 
RNA isolation and real-time PCR analysis of individual chicken cathelicidins. Each bar 
represents mean ± SEM of three chickens. Means with different letters are significantly 























































































Figure 5.Developmental expression of four chicken cathelicidins in the lung. Lungs 
were harvested from chickens of 2, 4, 7, 14, and 28 days of age and subjected for RNA 
isolation and real-time PCR analysis of individual chicken cathelicidins. Each bar 
represents mean ± SEM of three chickens. Means with different letters are significantly 
different (p< 0.05). 
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DEVELOPMENT OF A MASS SPECTROMETRIC ASSAY FOR CHICKEN  
FOWLICIDINS 
ABSTRACT  
Fowlicidin-1 is a recently identified chicken antimicrobial peptide with potent 
antibacterial activity. Fowl-1(6-26)-NH2, an amino-terminal five-amino-acid truncation 
analog of fowlicidin-1 with carboxyl-terminal amidation, is capable of killing drug 
resistant bacteria, such as methicillin-resistant Staphylococcus aureus both in vitro and in 
vivo, remains active at physiological salt concentrations and in the presence of serum. 
Therefore, fowl-1(6-26)-NH2 has potential for further development as a novel class of 
antibacterial drugs. However, it remains unknown about fowl-1(6-26)-NH2 with regard to 
its kinetics of absorption, distribution, metabolism, and excretion following in vivo 
administration. As a first step to estimate its pharmacokinetic parameters, we have sought 
to develop and validate a liquid chromatography and tandem mass spectrometry (LC-
MS/MS) approach to quantify fowl-1(6-26)-NH2. Extensive optimizations on mass 
spectrometer settings including capillary voltage, tube lens, scan time, and injection 
control settings were carried out to gain sensitive and accurate detection. 
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Our results showed that, after optimization, five different charge states of fowl-1(6-26)-
NH2 ranging from +2 to +6 were readily detected, with the most intense ion being 
501.31([M+5H]5+), followed by 626.39 ([M+4H]4+), 418.09 ([M+6H]6+), and 835.19 
([M+3H]3+). A concentration-response curve was also established fowl-1(6-26)-NH2 in 
the range of 0.05 - 5 µg/ml, with a R2 of 0.988. We further revealed that the peptide can 
be reliably detected when acetonitrile-treated plasma samples were diluted up to 5 
percent plasma before injection into LC-MS/MS. However, acetonitrile precipitation 
caused a loss of 70% of the peptide from plasma, suggesting that an alternative protein 
precipitation procedure or use of unprecipitated samples is needed for quantification of 
fowl-1(6-26)-NH2 in plasma. Collectively, these preliminary data have established a solid 
foundation on the quantification of the plasma concentrations of fowl-1(6-26)-NH2 
peptide, which will be essential in calculating pharmacokinetic parameters.  
INTRODUCTION 
Cathelicidins represent a large family of antimicrobial peptides with a highly conserved 
N-terminal pre-pro-sequence and a variable C-terminal mature peptide sequence (1). 
They have been found in various vertebrate species including mammals, birds, reptiles, 
and fishes (2-4). Fowlicidins 1-3 are chicken cathelicidins identified recently through a 
combination of genomic sequence screening and molecular cloning (5). The peptide 
sequences of the three fowlicidins indicate that they are homologous to each other, with 
fowlicidins 1 and 3 sharing 90% identity (5). Presence of cationic residues like arginine 
and lysine at the C-terminal region are suggestive of the positively charged nature of 
fowlicidins. Putatively mature fowlicidins 1-3 are devoid of cysteines and composed of 
26, 32 and 29 amino acid residues with a net charge of +8, +10 and +7 respectively (5). 
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Among the three fowlicidins, fowlicidin-1 adopts primarily an alpha helical structure 
with a kink at the center and a short flexible unstructured region at the N-terminal region 
(6). Studies with a series of synthetic fowlicidin-1 analogs with either amino- or 
carboxyl-terminal deletion demonstrated that fowl-1(6-26) with a deletion of the first five 
amino acids retained antibacterial activity (6, 7). The C-terminal amidation of fowl-1(6-
26) enhanced its stability in the presence of serum (8). Furthermore, fowl-1(6-26)-NH2 
reduced bacterial titers in the spleen of mice and protected mice from MRSA-induced 
lethal infection (8). Thus, fowl-1(6-26)-NH2 has potential for further development as a 
possible drug candidate for antimicrobial therapy. 
Pharmacokinetics describes the time course of absorption, distribution, metabolism, and 
excretion (ADME) of a drug in the body, which is essential information required in drug 
development. Pharmacokinetic parameters of a drug can be traditionally studied by 
employing techniques such as enzyme linked immunosorbent assay (ELISA). However, 
because of relatively low sensitivity, low specificity, and high costs associated with many 
of the traditional techniques (9, 10), liquid chromatography and tandem mass 
spectrometry (LC-MS/MS) has proven useful in pharmacokinetic studies of many drugs 
(11, 12). Such an approach has also been employed to study cationic AMPs such as NAB 
7061 and NAB 739 (13) as well as plectasin (14). In the case of plectasin, its linear 
response range was 4-1440 ng/mL by liquid chromatography-electrospray ionization- 
quadrapole time of flight (LC-ESI-QTOF) (14).The primary objective of the current 
study was to develop and optimize the LC-MS/MS settings for sensitive and accurate 




MATERIALS AND METHODS 
Fowl-1(6-26)-NH2 peptide preparation: Fowl-1(6-26)-NH2 peptide was commercially 
synthesized at 95% purity and dissolved in 0.1% formic acid and acetonitrile (50:50) for 
electrospray infusion. In the case of nanospray LC-MS/MS, the peptide was suspended in 
buffer A (0.1% formic acid), and serial 2-fold dilutions were prepared to derive a 
concentration-response curve. 
Precipitation of plasma proteins: Acetonitrile treatment was employed in the 
precipitation of plasma proteins as previously described (15). Mouse plasma (50 µL) was 
mixed with 150 µL of chilled acetonitrile, thoroughly vortexed, and incubated on ice for 
2 h to precipitate proteins. The precipitated proteins were then pelleted by centrifugation 
at 10,000 x g for 10 min at 4oC. The supernatant was transferred, aliquoted, and stored at 
-80 o C until further use. 
HPLC separation of fowl-1(6-26)-NH2: The peptide samples were separated on a 
NanoLC HPLC system (Eksigent), prior to mass spectrometry. The NanoLC system was 
equipped with a C18 column, a microwell plate autosampler and reservoirs containing 
mobile phase A (0.1% formic acid in water) and B (0.1% formic acid in acetonitrile). A 
total 10 µL of the sample was injected via the autosampler for each 20-min run. A linear 
30-90% acetonitrile gradient was applied at a flow rate of 300 nL/min for 15 min, 
followed by a reduction in the acetonitrile gradient from 90% to 30% in 1 min, which 
was then held constant for another 4 min (Table 1). Scan time and AGC settings were 
then optimized to achieve at least twenty points on the chromatographic peak. Each 
concentration of the peptide was subjected to at least 2-3 independent runs to obtain 
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replicate ion counts, which were expressed as mean ± SEM. For each run, a full MS scan 
was performed with a mass range of m/z 300-1500 in fourier transformation detector, 
followed by a MS/MS scan for the parent ion 626 ([M+4H]4+) → 772 (fragment m/z) in 
ion trap. 
Optimization of mass spectrometer settings: An LTQ Orbitrap XLTM Mass Spectrometer 
(Thermo Scientific MA, USA) connected to the NanoLC system was used to analyze the 
mass and concentration of the fowl1-1(6-26)-NH2 peptide. The instrument was tuned 
with electrospray infusion of 400 µg/ml of fowl-1(6-26)-NH2 in acetonitrile/0.1% formic 
acid (50:50) at a nominal flow rate of 80 nL/ min. The capillary voltage and tube lens 
were adjusted until the most intense ion of the peptide with ion counts of >106 were 
observed. In order to achieve optimal spray voltage, different voltages were applied and 
the spray was observed for 10 min until an appropriate taylor cone was noted. 
RESULTS 
Optimization of mass spectrometer settings and Liquid Chromatography conditions: To 
increase the accuracy and sensitivity in detection of ions of fowl-1(6-26)-NH2 peptide, 
various settings of the mass spectrometer were optimized following an electrospray 
infusion of the peptide at 400 µg/ml. For all experiments, the capillary voltage, capillary 
temperature, and tube lens, and spray voltage were finally set at 30 V, 199oC 56 V, and 
1.9 KV, respectively, to maintain a perfect taylor cone. The scan time and injection 
control settings were further adjusted. Under the factory default settings (Table 2), a 
10µL infusion of 400 µg/ml fowl-1(6-26)-NH2 only yielded two weak charge states, 
namely ([M+3H]3+ ) of 835 and ([M+4H]4+ ) of 626 (Fig. 1A). Under tuned settings 
(Table 2), several charge states of the peptide were readily revealed, with the most 
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intense ion being m/z 501 ([M+5H]5+), followed by 626 ([M+4H]4+) and 835 ([M+3H]3+) 
(Fig. 1B). 
The highest ion count was noted for m/z 501, followed by quadruple charged m/z 626. 
Other ions such as m/z 418 and m/z 835 were found at low ion intensity (Fig. 1B). Ion 
1225 ([M+2H] 2+) charge state was observed only at high concentrations (Table 3). In full 
scan, these charge states were calculated based on the distance between the isotopes 
formed by these masses. The charge state and the isotopic distribution of the respective 
ions were also demonstrated (see the inserts of Fig. 2A-D). Overall, results in all 
experiments showed a similar pattern of ion distribution in the following sequence: 
[M+5H]5+ (56% ± 5), [M+4H]4+ (28% ± 6), [M+6H]6+ (14% ± 4) and, [M+3H]3+ (2% ± 
2). Therefore, we concluded that fowl-1(6-26)-NH2 is multiply charged, ranging from +2 
to +6, consistent with the calculated peptide mass of 2502Da. 
Each precursor ion has produced characteristic product ions (Table 3). The SRM scan for 
all precursor ions was performed and fragmented with 35 percent collision energy. The 
product m/z 772 of precursor ion m/z 626 ([M+4H]4+) was shown to be the most abundant 
and detectable among the other product ions. This product ion was considered as the best 
transition to monitor the peptide. Execution of more number of scans in our experiment 
has reduced the number of chromatographic points and also the ion counts (data not 
shown). Hence, a single SRM scan was performed in ion trap for precursor ion, 626 and 
its product ion, 772 (626 → 772). Both parent ion and its fragment showed an identical 
retention time of 8.2 min (Fig. 3). 
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Quantification of fowlicidin peptide: To ensure that the optimized mass spectrometer 
settings can be used for quantitative measurement of fowl-1(6-26)-NH2, we first 
developed a 20-min HPLC protocol using a linear gradient of 30-90% acetonitrile. Under 
this protocol, the peptide showed a retention time between 7.8 to 8.2 min and was eluted 
at 56% acetonitrile. Serial 2-fold dilutions of the peptide were then prepared in 0.1% 
formic acid, ranging from 1.25 to 40 µg/ml, and subjected to LC-MS/MS under the 
optimized instrument settings. As shown in Fig. 4, total ion counts of all charge states 
showed a concentration-dependent increase with increasing concentrations of the peptide, 
with saturation of detection occurring at 10 µg/ml. 
To determine the lower limit of detection, serial 2-fold dilutions from 3.2 to 0.05 µg/ml 
were prepared. Response was estimated from the area of the product ion 772 of m/z 626
([M+4H]4+). The power trend line clearly demonstrated a good fit for response over 
concentration plot with an R2 value of 0.994 (Fig. 5). It is noteworthy that the ion counts 
have become unreproducible when the peptide concentration is below 25 ng/ml. The limit 
of detection was approximately 50 ng/ml. Collectively, our results indicated that the 
response curve for fowl-1(6-26)-NH2 is between 0.05 to 5.0 µg/ml using the LC-MS/MS 
approach that we developed. 
To determine the best scan between full and SRM modes for the quantification of fowl-
1(6-26)-NH2 peptide, serial two-fold dilutions from 3.2 to 0.2 µg/mL were prepared. The 
resulting data were double log (10) transformed and fitted simple linear regressions in 
Microsoft excel (Microsoft, Redmond, Washington). The resulting regression equation 
was used to back calculate the concentrations and percent deviation of the calibrants as 
compared to their nominal concentrations (Table 4 & Fig. 6). Based on R- squared value 
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and percent deviation from nominal concentrations, full scan was chosen as the most 
accurate method of constructing a calibration curve for fowl-1(6-26)-NH2 peptide. 
Further, to choose between single ion and combined total ion count in full scan mode for 
the quantification of the fowl-1(6-26)-NH2 peptide, similar approach was adopted. The 
single ion m/z 501 was considered as the best ion for comparison with the summated 
approach due to its high abundance. Based on R- squared values and percent deviation 
from nominal concentrations (Table 4 & Fig. 6), there was no difference between single 
ion and combined total ion counts. Therefore, we adopted full scan, combined total ion 
count for estimation of the amount of the fowl-1(6-26)-NH2 peptide in buffer and plasma. 
Influence of plasma on quantification of fowl-1(6-26)-NH2: In order to determine the 
impact of plasma on measurement of the peptide, mouse plasma proteins were first 
precipitated in acetonitrile in the ratio of 1:3. Clarified plasma was then diluted to 1, 2.5, 
and 5% plasma in 0.1% formic acid, followed by fortifying with fowl-1(6-26)-NH2 
peptide to a final concentration of 5 µg/ml. The same concentration of the peptide in 
0.1% formic acid was used as a positive control. Plasma fortified with peptide sample 
each was freshly prepared before each duplicate run on LC-MS/MS under the optimized 
instrument settings. The results indicated that inclusion of clarified plasma had a 
minimum impact on the quantification of the peptide, as the ion counts of the peptide 
were at least 70% in 5% plasma, relative to the peptide in 0.1% formic acid alone (Fig. 
7). Therefore, it suggests that the plasma samples could be diluted up to 5% with no 
impact on peptide detection before loading on to the LC-MS/MS. 
To study the influence of acetonitrile precipitation of plasma proteins on the recovery of 
the peptide, we next fortified 100 percent mouse plasma with fowl-1(6-26)-NH2 peptide 
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to 1 µg/ml, then proceeded with acetonitrile treatment in the ratio of 1:3 as described 
above. Clarified plasma fortified with peptide sample was then subjected to LC-MS/MS. 
As compared with peptide alone, only 29 percent of the fowl-1(6-26)-NH2 peptide was 
recovered following acetonitrile precipitation procedure (Fig. 8), suggesting a large 
proportion of the peptide was precipitated. 
DISCUSSION 
 In this study, we have developed an LC-MS/MS approach for detection of fowl-1(6-26)-
NH2, a short antimicrobial peptide analog with commercial potential in antimicrobial 
therapy. The developed method provides a preliminary idea in detection of fowl-1(6-26)-
NH2 in biological matrix, which will be useful in estimating pharmacokinetic parameters 
during pharmacokinetic study. 
We developed a preliminary method for the detection of fowl-1(6-26)-NH2 peptide in full 
and SRM scan modes. The method development varies from peptide to peptide. Wilbert 
et al., demonstrated the quantitative analysis of multiple charged compound NR58-3.14.3 
(A), a panchemokine inhibitor in biological fluids choosing selected ion monitoring. 
Selected ion monitoring (SIM) was applied to quantify the peptide by combining ion 
currents of all three charges to generate a total area under curve (16). They also reported 
that choosing a single ion for quantitative analysis have produced data with relative 
standard deviation (RSD) of more than 20 percent. But, in our study, percent deviation of 
back calculated value from the observed values for both single ion and combined ion 
count were in acceptable limits (Table 4 and fig. 6). However, we have chosen combined 
total ion counts for our analysis. Therefore, our results have proven to produce a 
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reproducible LC-MS/MS method for detection of fowl-1(6-26)-NH2 peptide using full 
scan, where this method can be a useful tool in further analyzing other fowlicidin 
analogs. 
Limited preliminary data regarding the detection and concentration-response curve of 
fowl-1(6-26)-NH2 peptide were obtained from the present study. A follow up study 
would be required to estimate the limit of detection (LOD) and lower limit of 
quantification (LLOQ) of fowl-1(6-26)-NH2 peptide in plasma. The lower limit of 
quantification can be defined as the lowest concentration of an analyte that can be 
quantified with a precision and accuracy equal to or better than 20 percent (17), while, 
the limit of detection describes the analyte concentration yielding a signal that 
significantly differs from that of the blank samples (18). However, our preliminary data 
provides an idea of fowl-1(6-26)-NH2 response in buffer and plasma, which will be 
useful in additional experiments. Further work is expected to include biological samples 
and inclusion of other fowlicidin analogs. 
A low recovery rate was observed for fowl-1(6-26)-NH2 following plasma precipitation 
by 75 percent acetonitrile. In fact, more than 70 % of the peptide was lost following 
precipitation (Fig. 8), which suggested that the peptide might have precipitated or bound 
to certain plasma proteins. However, precipitation of plasma proteins before 
chromatographic separation is necessary to increase the availability of free drugs and to 
remove extraneous proteins and other interfering agents that may bind to the column 
which decreases the life of the column, suppress ionization, shifts the retention time, and 
alters peak shape. Therefore, a further study has to be performed to prevent loss of the 
peptide either by employing internal standards, lower acetonitrile concentrations, and or 
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use of methanol or ammonium acetate as an alternate plasma precipitants (15). Internal 
standards such as isotope analogs, stereoisomers including atropisomers and 
diastereomers can be used to correct for analyte loss during sample preparation, matrix 
effect and, drifting ion currents of mass spectrometers (16). Wolf et al., reported the 
addition of protease or other inhibitors to prevent the degradation of peptides in the 
biological matrix (19). Lower acetonitrile concentrations (50% and 67%) were found to 
give a better recovery for two other antimicrobial cationic peptides, NAB 7061 and NAB 
739 (13). 
Alternatively, peptide-containing plasma samples may be directly subjected to LC-
MS/MS analysis in order to minimize peptide loss during precipitation. An increased 
sensitivity in detection of a peptide in biological fluids without any pretreatment was 
reported (20). The utility of direct injection of plasma could be examined by injection of 
un-manipulated plasma samples with determination of the minimum dilutions required 
without interfering with the sensitivity and accuracy in fowl-1(6-26)-NH2 detection. 
In summary, we demonstrated the feasibility of quantitation of fowl-1(6-26)-NH2 by LC-
MS/MS and revealed that it can be reliably detected in the range of 0.05- 5 µg/mL. This 
preliminary study will be helpful in determining the optimal MS/MS conditions for 
analysis of fowl-1(6-26)-NH2, which will lead to a method suitable for use in mouse 
plasma. 
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Table 1: Gradient used for separation of fowl-1(6-26) NH2 peptide. 













Note: %A: 0.1% formic acid in water; % B: 0.1% formic acid in acetonitrile. 
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Table 2: Optimization of the scan time and injection control settings in ion trap and 
FT detector. 
 Scan Time Setting 
(ms) 


























3.00e + 04 
1.00e + 04 
1.00e + 04 
3000 
 
3.00e + 04 
1.00e + 04 















2.00e + 05 
1.00e + 05 
1.00e + 05 
 
3.00e + 05 
1.00e + 05 
3000 
Note: a AGC- Automatic gain control, bSIM- Selective ion monitoring, cMSn- Multiple 





Table 3: Mass over charge ratios (m/z) of precursor and product ions of                
fowl-1(6-26)-NH2. 
















Note: a SRM- Selective reaction monitoring. 
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0.4 13 14 32 
0.8 7 8 20 
1.6 11 11 1 
3.2 4 4 27 
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Figure 1. Mass spectra of fowl-1(6-26)-NH2 peptide before (A) and after (B) 
optimization of instrument setting.  The spectra were obtained by direct electrospray 





Figure 2. Nanospray mass spectrum of 
Gaussian peaks of four major charge states including 
([M+4H]4+) (B), 835.19 ([M+3H]
isotopic distributions for each charge state were also indicated in the insert. of all ions, 
501 ([M+5H]5+) was abundantly produced.
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Figure 3. LC-MS/MS full and SRM chromatograms of fowl-1(6-26)-NH2.The ions of 









Figure 4. Concentration-response curve of fowl-1(6-26)-NH2 by LC-MS/MS. Serial 
2-fold dilutions of the peptide in 0.1% formic acid were subjected to LC-MS/MS 
analysis, with duplicate runs for each dilution. The total ion counts of all charge states 
were recorded for each concentration and saturation of the fowl-1(6-26)-NH2 peptide was 






















Figure 5. Concentration-response curve of fowl-1(6-26)-NH2 in linear scale. Serial 2-
fold dilutions of the peptide in 0.1% formic acid were subjected to LC-MS/MS analysis, 
with duplicate runs for each dilution. Response was estimated from the area of product 
ion (772) of the precursor ion 626 ([M+4H]4+). The concentrations used were 0.05, 0.1, 
0.2, 0.4, 0.8, 1.6, and 3.2 µg/ml. A good fit of concentration over response plot was noted 
in power trend line with R2 value of 0.994. 
  


















Figure 6: Concentration response curves of
(combined total ion count and single ion count) scans. 
deviation, full scan mode was adopted.
count); C full scan (single ion 
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Figure 7. Influence of plasma on LC-MS/MS quantification of fow1-1(6-26)-NH2. 
Mouse plasma  samples were precipitated with acetonitrile and then diluted to 1, 2.5, and 
5%  plasma in 0.1% formic acid, followed by addition of fowl-1(6-26)-NH2 to 
5µg/ml.10µl of the samples were injected into LC-MS/MS at a flow rate of 300nl/min. 




































Figure 8. Effect of acetonitrile precipitation on the recovery of fow1-1(6-26)-NH2. 
Peptide was added in plasma which was then precipitated with 75% acetonitrile. Spiked 
plasma (10µL) was injected into LC-MS/MS and the amount of fowl-1(6-26)-NH2 
peptide recovered was compared with that of positive control (peptide alone). It was 
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Scope and Method of Study: The purposes of the study are to determine the tissue and 
developmental expressions of chicken cathelicidins and to develop a mass 
spectrometric assay for quantification of chicken cathelicidins. RNA was isolated 
from a panel of chicken tissues of different ages and real-time PCR was 
performed to measure the gene expression levels of four chicken cathelicidins. A 
mass spectrometric method was also developed by employing LC-MS/MS for 
quantification of fowl-1(6-26)-NH2, a chicken cathelicidin peptide analog.  
  
 
Findings and Conclusions: Four chicken cathelicidins were widely expressed in a variety 
of tissue types, with fowlicidins 1-3 showing a more similar pattern than cathelicidin B1. 
Lung showed the highest expression of fowlicidins 1-3, while cathelicidin B1 was 
expressed most abundantly in bursa of Fabricius. Four cathelicidins were differentially 
expressed during the early stages of development, largely with a gradual increase in bursa 
and cecal tonsil, two important immune organs in intestinal host defense. Collectively, 
our study of tissue and developmental expression patterns of four chicken cathelicidins 
has led to a better understanding of the chicken innate immunity as well as the 
development of the innate immune system. In the LC-MS/MS assay, five different charge 
states of fowl-1(6-26)-NH2 ranging from +2 to +6 were detected, with the most intense 
ion being 501.31 ([M+5H]5+), followed by 626.39 ([M+4H]4+), 418.09 ([M+6H]6+), and 
835.19 ([M+3H]3+). Results also showed the response curve for fowl-1(6-26)-NH2 is 
between 0.05 to 10.0 µg/ml with saturation of detection occurring above 10.0 µg/ml 
using the LC-MS/MS approach that we developed. Taken together, these preliminary 
data have established a solid foundation on the quantification of the plasma 
concentrations of fowl-1(6-26)-NH2 peptide, which will be essential in calculating 
pharmacokinetic parameters. 
  
 
 
 
